Skip to content

Autosomal Dominant Mendelian Susceptibility To Mycobacterial Diseases Due To A Partial Deficiency C5679889

Published: July 22, 2026Updated: August 20, 2026

A genetic condition causing increased susceptibility to mycobacterial infections due to partial immune deficiency. Inherited in autosomal dominant pattern. Requires careful monitoring and aggressive treatment of infections.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Recurrent pulmonary tuberculosis infection

!

Disseminated BCG infection

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Cervical lymphadenitis

(hematologic)

Chronic granulomatous skin lesions

(integumentary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Interferon-gamma Therapy

Recombinant IFN-gamma administered subcutaneously to enhance macrophage activation and improve defense against mycobacterial pathogens.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Antimycobacterial Prophylaxis

Preventive treatment with agents such as isoniazid or rifampin to protect against common opportunistic mycobacterial infections.

medication

Additional treatment options

Aggressive Treatment of Active Infection

Combination antimicrobial therapy for documented mycobacterial disease, often requiring prolonged courses with multiple agents.

medication

Regular Tuberculin Skin Testing and IGRA

Periodic screening for latent mycobacterial infection to enable early intervention before disseminated disease develops.

monitoring

Environmental Exposure Reduction

Avoidance of high-risk environments such as aquariums, soil exposure, and regions endemic for atypical mycobacteria.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autosomal Dominant Mendelian Susceptibility To Mycobacterial Diseases Due To A Partial Deficiency C5679889?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol. 2014.

other2014
2

Zhang SY, Boisson-Dupuis S, Chapgier A, et al. Inborn errors of the IL-12/IFN-γ axis in patients with mendelian susceptibility to mycobacterial infection. J Clin Immunol. 2008.

review2008
3

International Union of Immunological Societies. Primary Immunodeficiency Diseases: A Report of an IUIS Expert Committee. Front Immunol. 2021.

guideline2021
4

Rosain J, Kong XF, Boisson-Dupuis S, et al. Mendelian susceptibility to mycobacterial disease: 2018 International Union of Immunological Societies (IUIS) update. J Clin Immunol. 2018.

review2018

Medication Comparisons

Compare medications used to treat Autosomal Dominant Mendelian Susceptibility To Mycobacterial Diseases Due To A Partial Deficiency C5679889. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy